| Literature DB >> 32173199 |
Osamu Ohno1, Takuro Terasaki2, Takuya Sano2, Yuki Hitomi2, Junichiro Miyamoto2, Kenji Matsuno3.
Abstract
Lipopolysaccharides (LPS) are associated with various inflammatory diseases; therefore, the inhibition of LPS-induced nitric oxide (NO) production may have extensive therapeutic applications. We searched for inhibitors of NO production in the LPS-stimulated murine macrophage-like cell line RAW264.7 from MeOH extracts of marine organisms. The MeOH extract of the marine cyanobacterium Okeania sp., collected in Okinawa, Japan, showed inhibitory activity. Biseokeaniamide A was isolated from the MeOH extract by chromatographic separation. Biseokeaniamide A inhibited NO production without cytotoxicity. It reduced inducible nitric oxide synthase levels and suppressed the expression of IL-1β in LPS-stimulated RAW264.7 cells. Biseokeaniamide A did not inhibit IκBα degradation but inhibited IκBα expression. Thus, biseokeaniamide A, a naturally occurring lipopeptide, was identified as a selective inhibitor of LPS signal transduction.Entities:
Keywords: Biseokeaniamide A; Lipopolysaccharide; Marine cyanobacterium; Nitric oxide; RAW264.7
Mesh:
Substances:
Year: 2020 PMID: 32173199 DOI: 10.1016/j.bmcl.2020.127069
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823